Red Blood Cell Storage Lesion

The past two decades have witnessed increased scrutiny regarding efficacy and risk of the once unquestioned therapy of red blood cell (RBC) transfusion. Simultaneously, a variety of changes have been identified within the RBC and storage media during RBC preservation that are correlated with reduced...

Full description

Bibliographic Details
Main Authors: Daryl J. Kor, Camille M Van Buskirk, Ognjen Gajic
Format: Article
Language:English
Published: Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina 2009-10-01
Series:Bosnian Journal of Basic Medical Sciences
Subjects:
Online Access:https://www.bjbms.org/ojs/index.php/bjbms/article/view/2750
id doaj-0efa173984de4003af3a1dc56c1ac37e
record_format Article
spelling doaj-0efa173984de4003af3a1dc56c1ac37e2020-11-24T22:01:58ZengAssociation of Basic Medical Sciences of Federation of Bosnia and HerzegovinaBosnian Journal of Basic Medical Sciences1512-86011840-48122009-10-019110.17305/bjbms.2009.2750460Red Blood Cell Storage LesionDaryl J. Kor0Camille M Van Buskirk1Ognjen Gajic2Mayo Clinic, Rochester, MNMayo Clinic, Rochester, MNMayo Clinic, Rochester, MNThe past two decades have witnessed increased scrutiny regarding efficacy and risk of the once unquestioned therapy of red blood cell (RBC) transfusion. Simultaneously, a variety of changes have been identified within the RBC and storage media during RBC preservation that are correlated with reduced tissue oxygenation and transfusion-associated adverse effects. These alterations are collectively termed the storage lesion and include extensive biochemical, biomechanical, and immunologic changes involving cells of diverse origin. Time-dependent falls is 2,3-diphosphoglycerate, intracellular RBC adenosine triphosphate, and nitric oxide have been shown to impact RBC deformability and delivery of oxygen to the end-organ. The accumulation of biologic response modifiers such as soluble CD40 ligand (sCD40L), lysophosphatidylcholine (lyso-PC), and Regulated on Activation, Normal T-cell Expressed and Secreted (RANTES) have been associated with altered recipient immune function as well. This review will address the alterations occurring within the RBC and storage media during RBC preservation and will address the potential clinical consequence thereof.https://www.bjbms.org/ojs/index.php/bjbms/article/view/2750red blood cell transfusionstorage lesiontransfusion effiacacytransfusion risks
collection DOAJ
language English
format Article
sources DOAJ
author Daryl J. Kor
Camille M Van Buskirk
Ognjen Gajic
spellingShingle Daryl J. Kor
Camille M Van Buskirk
Ognjen Gajic
Red Blood Cell Storage Lesion
Bosnian Journal of Basic Medical Sciences
red blood cell transfusion
storage lesion
transfusion effiacacy
transfusion risks
author_facet Daryl J. Kor
Camille M Van Buskirk
Ognjen Gajic
author_sort Daryl J. Kor
title Red Blood Cell Storage Lesion
title_short Red Blood Cell Storage Lesion
title_full Red Blood Cell Storage Lesion
title_fullStr Red Blood Cell Storage Lesion
title_full_unstemmed Red Blood Cell Storage Lesion
title_sort red blood cell storage lesion
publisher Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina
series Bosnian Journal of Basic Medical Sciences
issn 1512-8601
1840-4812
publishDate 2009-10-01
description The past two decades have witnessed increased scrutiny regarding efficacy and risk of the once unquestioned therapy of red blood cell (RBC) transfusion. Simultaneously, a variety of changes have been identified within the RBC and storage media during RBC preservation that are correlated with reduced tissue oxygenation and transfusion-associated adverse effects. These alterations are collectively termed the storage lesion and include extensive biochemical, biomechanical, and immunologic changes involving cells of diverse origin. Time-dependent falls is 2,3-diphosphoglycerate, intracellular RBC adenosine triphosphate, and nitric oxide have been shown to impact RBC deformability and delivery of oxygen to the end-organ. The accumulation of biologic response modifiers such as soluble CD40 ligand (sCD40L), lysophosphatidylcholine (lyso-PC), and Regulated on Activation, Normal T-cell Expressed and Secreted (RANTES) have been associated with altered recipient immune function as well. This review will address the alterations occurring within the RBC and storage media during RBC preservation and will address the potential clinical consequence thereof.
topic red blood cell transfusion
storage lesion
transfusion effiacacy
transfusion risks
url https://www.bjbms.org/ojs/index.php/bjbms/article/view/2750
work_keys_str_mv AT daryljkor redbloodcellstoragelesion
AT camillemvanbuskirk redbloodcellstoragelesion
AT ognjengajic redbloodcellstoragelesion
_version_ 1725837678895693824